FindTrial
Sign In

Transcutaneous Acupoint Electrical Stimulation Composite Low-Dose Sufentanil Pretreatment Reduces The Incidence And Severity Of Myoclonus Induced By Etomidate, During Anesthetic Induction

Transcutaneous Acupoint Electrical Stimulation Composite Low-Dose Sufentanil Pretreatment Reduces The Incidence And Severity Of Myoclonus Induced By Etomidate, During Anesthetic Induction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009084
Enrollment
Unknown
Registered
2016-08-25
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myoclonus induced by etomidate

Interventions

I:Sham acupuncture+NS
II:electro-acupuncture+NS
III:Sham acupuncture+Sufentanil
IV:electro-acupuncture+Sufentanil

Sponsors

First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. written informed consent; 2. ASA I-II; 3. Aged 20-55 years; 4. Scheduled for elective hysteroscopic surgery.

Exclusion criteria

Exclusion criteria: with incision, scar or skin infection in heju or waiguan position; the history of study related drug allergy; the history of spinal surgery; sinus bradycardia;severe neurologic systerm diseases; severe respiratory system disease; severe cardiovascular system disease; any other researchers considered unsuitable for patients to participate.

Design outcomes

Primary

MeasureTime frame
Severity Of Myoclonus;—

Countries

China

Contacts

Public ContactJunlu Wang

First Affiliated Hospital of Wenzhou Medical University, Wenzhou

wangjunlu973@163.com+86 13806689854

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026